CYCC icon

Cyclacel Pharmaceuticals

17 hedge funds and large institutions have $782K invested in Cyclacel Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
17
Holders Change
Holders Change %
0%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
2
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$506K 374,155 +26,709 +8%
VF
2
Virtu Financial
New York
$53K 39,613 -159,851 -80%
RJFSA
3
Raymond James Financial Services Advisors
Florida
$41K 30,125
PAM
4
Panagora Asset Management
Massachusetts
$40K 29,531 +29,531 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$29K 21,692
WS
6
Wedbush Securities
California
$28K 21,000 +21,000 New
Renaissance Technologies
7
Renaissance Technologies
New York
$20K 14,900 +14,900 New
Northern Trust
8
Northern Trust
Illinois
$18K 13,399 +13,399 New
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$17K 12,240
AWS
10
AJ Wealth Strategies
New York
$17K 12,677
RE
11
RBC Europe
United Kingdom
$7.54K 5,586
UBS Group
12
UBS Group
Switzerland
$4K 2,956 +801 +37%
BlackRock
13
BlackRock
New York
$1K 796
Two Sigma Investments
14
Two Sigma Investments
New York
-70,310 Closed
Citadel Advisors
15
Citadel Advisors
Florida
-61,900 Closed
OAM
16
Oxford Asset Management
United Kingdom
-31,827 Closed
Deutsche Bank
17
Deutsche Bank
Germany
-2,803 Closed
CA
18
Calton & Associates
Florida
-2,000 Closed
Morgan Stanley
19
Morgan Stanley
New York
$0 229 -31 -12%
DOA
20
D'Orazio & Associates
Virginia
$0 100
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$0 1
SFM
22
Signet Financial Management
New Jersey
$0 23 +23 New